The Impact of the Health Care Consolidation Trend
(from H&HN Mag)
Some megadeals in the medical device and drug industries — totaling $170 billion — hold significant implications for hospitals and health systems.
Holdings (the second largest orthopedic device manufacturer) agreed to
acquire Biomet (No. 4 in orthopedic devices) for $13.35 billion — the
biggest device deal since the 2012 Johnson & Johnson acquisition of
Synthis for $21.2 billion.
- Novartis and Glaxo Smith Kline
announced a $20 billion deal to swap assets strengthening the core
businesses in each organization.
- Valeant’s $45 billion hostile
bid to acquire Allergan and its Botox franchise, financed in part with
Pershing Capital, continued to get attention.
- Pfizer announced a $99 billion deal to acquire Astra Zeneca.